Urology Faculty

Mark L. Jordan M.D., Harris L. Willits Professor and Chief, Division of Urology, UMDNJ-NJMS, Chief of Urology, University Hospital, Newark, NJ.

Mark L. Jordan, MD is a graduate of the University of Toronto Medical School (1977) and completed his residency in urology at the University of Toronto under the mentorship of Dr. Charles Robson and Dr. Andrew Bruce (1983). He then completed a fellowship in renal transplantation and renovascular surgery at the Cleveland Clinic with Dr. Andrew Novick (1983) followed by a research fellowship in immunology at the University of Minnesota under Dr. Richard Simmons (1984-1986). He returned to the University of Toronto as an Assistant Professor of Surgery (Urology) in 1986. He was recruited to the University of Pittsburgh as an Associate Professor of Surgery in 1989 where he remained until 2003, advancing to Professor of Urology with tenure and Director of the Urologic Renal Transplant Division at the University of Pittsburgh Medical Center and the Pittsburgh Veterans Administration Medical Center. In 2003, Dr. Jordan was appointed as the Harris L. Willits Professor and Chair and Program Director of the Division of Urology in the Department of Surgery at the UMDNJ-New Jersey Medical School.

Dr. Jordan has received numerous awards and honors during his career, including "Best Doctors in Pittsburgh "and "Best Doctors in America ". He has served as President of the Urologic Society for Transplantation and Vascular Surgery, on the Examination Committee for the American Board of Urology, on the Editorial Board of Transplantation and reviewer for many scientific journals. Dr. Jordan is recognized for his expertise in complex renal and vascular surgery, transplantation, and urologic oncology. Dr. Jordan's funded research focuses on dendritic cell immunobiology, cytokine and cellular mechanisms of donor specific hyporeactivity, and immunologic therapy for prostate cancer. He has published more than 180 journal articles and written 12 chapters in medical textbooks.

Hossein Sadeghi-Nejad, M.D.

Hossein Sadeghi-Nejad, M.D. graduated Magna Cum Laude from Bowdoin College in Brunswick, Maine where he was the recipient of the prestigious Goodwin Commencement Prize. He received his medical doctorate from the McGill University School of Medicine in Montreal, Canada and served as an intern and resident in general surgery at the University of California in San Francisco . Dr. Sadeghi-Nejad completed his urological residency and fellowship training in Male Reproductive Medicine (infertility and erectile dysfunction) and microsurgery at the Boston University Medical Center under the auspices of Drs. Robert Krane, Irwin Goldstein, and Robert Oates.

Currently, Dr. Sadeghi-Nejad is Associate Professor in the Division of Urology, Department of Surgery at UMDNJ New Jersey Medical School, Chief of Urology at the New Jersey Veterans Affairs Hospitals , and the Director of the Center for Male Reproductive Medicine at the Hackensack University Medical Center . Dr. Sadeghi-Nejad has been selected for the last 3 editions of Castle Connolly's Top Doctors: New York Metro Area, as well as New Jersey Monthly magazine's "Best Doctors in New Jersey ". Dr. Sadeghi-Nejad is certified by the American Board of Urology and is a member of numerous professional organizations including the American Urological Association, The Sexual Medicine Society of North America (SMSNA- committee chairman), and the American Society of Reproductive Medicine (ASRM). Dr. Sadeghi-Nejad was elected as Committee Chairperson for the Sexual Medicine Society of North America (audits) and the Society for Study of Male Reproduction (web development). He is a scientific reviewer for numerous peer-reviewed journals and serves on the editorial board of the Journal of Sexual Medicine.

Georgi Guruli, M.D.

Georgi Guruli, M.D. received his medical degree from the Tbilisi State Medical University (Georgia, Russia), and his Ph.D. degree from the National Cancer Research Center (Moscow, Russia). He then completed his urologic surgery residency program at the University of Pittsburgh Medical Center. After residency, Dr. Guruli completed a fellowship in urologic oncology in the Department of Urology at the University Of Pittsburgh School of Medicine.

In 2003, Dr. Guruli joined the Division of Urology at UMDNJ - New Jersey Medical School, as an Assistant Professor. His clinical interests include the treatment of bladder cancer and other genitourinary malignancies, as well as the utilization of various methods of urinary diversion. Dr. Guruli's research interests include general immunology as well as immunology and immunotherapy of prostate cancer. He is the recipient of the Physician Research Training Grant from the Department of Defense. Dr. Guruli is certified by the American Board of Urology and he is a member of the American Urological Association and American Association for Cancer Research.

Neil D. Sherman, M.D.

Neil D. Sherman, M.D., a native of Baltimore, Maryland , graduated from New York Medical College , Valhalla , New York (1998) and completed his residency in urologic surgery at UMNDJ � New Jersey Medical School (2004). After residency, Dr. Sherman was a fellow in Reconstructive Urology, Female Urology and Urodynamics under the mentorship of Dr. George Webster at Duke University Medical Center in Durham, North Carolina .

Dr. Sherman is certified by the American Board of Urology and currently he is the Director of Reconstructive and Female Urology in the Division of Urology, Department of Surgery at UMDNJ � New Jersey Medical School. Dr. Sherman's areas of clinical interest include reconstruction of the lower urinary tract and bladder dysfunction for both men and women. For male patients, Dr. Sherman has extensive experience in the evaluation and treatment of male urethral stricture disease. Dr. Sherman also has expertise in the diagnosis and treatment of female pelvic organ prolapse. Additionally, Dr. Sherman utilizes video urodynamics to more accurately characterize complex voiding problems and urinary incontinence in male and female patients.

Dr. Sherman's research extends from his busy clinical practice. In particular he is active in the evaluation of graft materials for the treatment of pelvic organ prolapse and investigating novel therapies for the improvement of bladder function and treatment of urinary incontinence. Dr. Sherman has written textbook chapters on male urethral stricture disease and various topics in the area of female urology. In addition, he has published his work in multiple peer-reviewed journals and presented at regional, national, and international meetings.

Patricia Gilhooly, M.D.

Patricia Gilhooly, M.D. graduated from Columbia University College of Physicians and Surgeons and completed her surgical internship and urologic surgery residency training at Columbia Presbyterian Hospital in New York City. In 1995, Dr. Gilhooly was appointed Assistant Professor in the Division of Urology of the Department of Surgery, UMDNJ - New Jersey Medical School.

Dr. Gilhooly's specialty interests include neurourology, male and female voiding dysfunction and urinary incontinence, female urology, disorders of the pelvic floor, pelvic floor reconstruction, interstitial cystitis and female sexual dysfunction. She has a particular interest in neurogenic bladder dysfunction associated with multiple sclerosis and utilizes neuromodulation therapies including Interstim and botulinum toxin (BOTOX) in appropriate patients. Having been the principal investigator in over 20 clinical trials, she has received multiple grants for the study of urinary incontinence, sexual dysfunction, interstitial cystitis, urinary tract infection and prostatic diseases.

Beverly E. Barton, Ph.D

Dr. Beverly E. Barton received her B. A. in biology from The Johns Hopkins University; her Sc.M. in biochemistry from The Johns Hopkins University, School of Hygiene and Public Health; and her Ph.D. in Medical Microbiology (Immunology) from Stanford University. Currently, Dr. Barton is Assistant Professor in the Division of Urology of the Department of Surgery at UMDNJ - New Jersey Medical School.

Dr. Barton's major research interests include the use of cell-targeted peptide nucleic acids for treating prostate cancer and the role of IL-6 signaling by STAT3 in prostate cancer. She has received several awards, most recently from the Society for Basic Urological Research (Investigator Travel Award), the Paul Ehrlich Symposium of the World Dosing Association for Chemotherapy (the Paul Ehrlich Magic Bullet Award), and an Investigator Award for the Prouts Neck Biannual Prostate Cancer Meeting. Dr. Barton has been an Associate Editor for The Journal of Immunology and currently is on the Editorial Board of the American Association of Cancer Research journals.

Hosea F. Huang, M.D.

Hosea F. S. Huang, Ph.D. received his doctorate degree in reproductive physiology from the University of Georgia (Advisor: A. D. Johnson, Ph.D.) and post-doctoral training in reproductive endocrinology from Columbia University College for Physician and Surgeon ( Mentor : Wylie C. Hembree, MD). After serving as a research associate for several years at Columbia , he joined the Max Planck Clinical Research Unit for Reproductive Medicine (Director: Professor Eberhard Nieshlag, MD) as a Scientist from 1981 to 1984. He returned to the United States in 1985 and joined the UMD-New Jersey Medical School Department of Anatomy where he taught Human Gross Anatomy and conducted research in male reproductive physiology emphasizing androgen and retinoid regulation of spermatogenesis. In 1989 he joined Department of Surgery Division of Urology, and is currently a research professor in the Department.